(Q37722460)

22 August 2017

1 reference

title

Adverse effects of chronic opioid therapy for chronic musculoskeletal pain (English)

1 reference

22 August 2017

0 references

0 references

0 references

1

Leslie J Crofford

1 reference

PubMed ID

20357788

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Nature Reviews Rheumatology

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

4

1 reference

22 August 2017

191-197

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2010.24

22 August 2017

0 references

cites work

Mechanisms underlying morphine analgesic tolerance and dependence

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Glia: novel counter-regulators of opioid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Predictors of opioid misuse in patients with chronic pain: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Major increases in opioid analgesic abuse in the United States: concerns and strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

A difficult balance--pain management, drug safety, and the FDA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Drug crime is a source of abused pain medications in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Source of drugs for prescription opioid analgesic abusers: a role for the Internet?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Role of urine toxicology testing in the management of chronic opioid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Reward processing by the opioid system in the brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Mu opioid receptor: a gateway to drug addiction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid abuse and brain gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Placebo effects on human mu-opioid activity during pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Neuroimaging study of placebo analgesia in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Placebo-induced changes in spinal cord pain processing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Direct evidence for spinal cord involvement in placebo analgesia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid Therapy for Chronic Pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid-induced hyperalgesia: a qualitative systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Nociception increases during opioid infusion in opioid receptor triple knock-out mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Altered quantitative sensory testing outcome in subjects with opioid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Decreased central mu-opioid receptor availability in fibromyalgia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Sleep-disordered breathing and chronic opioid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Reversal of sleep-disordered breathing with opioid withdrawal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Neuroendocrinology of autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Opioid-induced immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Effects of opioid tolerance and withdrawal on the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Oral or transdermal opioids for osteoarthritis of the knee or hip

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Pain management in fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.24

Effectiveness of opioids in the treatment of chronic non-cancer pain.

31 March 2020

1 reference

12 December 2020

Opioid induced hyperalgesia: clinical implications for the pain practitioner

1 reference

12 December 2020

Significant pain reduction in chronic pain patients after detoxification from high-dose opioids

1 reference

12 December 2020

Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.24

1 reference

22 August 2017

1 reference

PubMed ID

20357788